Authors including Roche, BM etc. etc. discuss similar function to Herceptin (trastuzumab)
Noting subsequently that (aside from tolerability issues) Herceptin has an issue in relation to perverse issues around Her expression decline increasing risk of progression..
Interesting comparisons...
Ann: Prestigious Research Journal Publish HER-Vaxx Phase 1B Data, page-27
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $240.9K | 21.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 9709195 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 12254839 | 53 |
View Market Depth
| Last trade - 13.50pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |